Clinical Trial Update: An Open Study Assessing the Safety and Tolerability of U3-1784 [Phase 1]

View source ↗

Summary

Phase 1 open-label study to assess safety and tolerability of the investigational drug U3-1784 in patients with advanced solid tumors and hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• U3-1784

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Solid Tumors, Hepatocellular Cancer (HCC) | Phase 1 | Status: TERMINATED